Potential cost-effectiveness of therapeutic drug monitoring in patients with resistant hypertension

Abstract

Therapeutic drug monitoring presents a potential cost-effective healthcare intervention in patients diagnosed with resistant hypertension. Importantly, this finding is valid for a wide range of patients, independent of sex and age.